Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
affirmatively, Akt, alvespimycin, androgen, antagonism, antagonist, antigen, ASCO, ascribed, Astex, AstraZeneca, attacking, authoritative, bone, Budget, chaperone, chaperoned, chose, circulating, clause, clearer, cMet, cohort, competitor, composition, Conference, Conservation, convey, cyclopamine, deadline, Deduct, deductibility, deny, died, disabled, DiscoverEase, docetaxel, dramatically, duration, elderly, encumber, EORTC, Error, evolution, exacerbate, exemption, exert, exploit, export, extremely, FDAAA, featuring, FIN, folded, formally, franchise, GAAP, geldanamycin, Gleevec, hierarchy, hormone, HRPC, hydrochloride, imatinib, Importantly, inappropriate, inexpensive, inInternal, injunctive, interstate, interventional, Justice, kinase, levy, linked, logo, malignancy, malignant, melanoma, men, mitigate, MMA, Modernization, necessitate, necessitating, Nominating, noncontrolling, nonrefundable, Notwithstanding, occasionally, Occupational, orderly, organizational, orphan, outlined, pendency, physician, pivotal, prescription, pretreated, principle, problem, prohibited, proven, qui, radiographic, rare, ratified, rational, rebate, recall, reconciliation, reformulate, regained, removal, reoccurrence, representational, Reseller, Resource, respond, retaspimycin, revoke, revoked, seize, seizure, Senate, shortly, skin, Smoothened, soft, stability, stabilization, stable, Steve, STS, subtenant, sued, sunitinib, sustain, Sutent, synergy, tam, tanespimycin, Taxotere, tender, testosterone, twenty, unapproved, unbenefited, underwent, undesignated, unfair, unmutated, unobtainable, unreasonable, unresectable, untitled, unused, user, vehicle, vendor, violate, voluntary, waiting, waive, waived, warning, weaken, week, women
Removed:
added, agency, assign, attracting, avoid, biochemical, budgetary, certificate, certification, cessation, challenged, delivery, detailed, discrete, duly, Ernst, Europe, eventual, favorable, functional, generating, hand, harry, hire, hixson, II, implemented, improper, incorporation, instituted, interaction, jr, led, liquidation, list, listed, LLP, long, michael, negotiating, nonstatutory, optimization, optimizing, permanent, preserve, promptly, proof, purity, realize, recover, recoverable, rendered, requirement, resolved, restrict, reviewed, revised, Rule, run, satisfactory, separately, shortened, skilled, studied, succeed, suit, surveillance, susceptible, technological, thereto, thereunto, treated, trend, Trust, typical, undergoing, undersigned, uneconomical, unenforceable, venuti, waste, Young
Filing tables
Filing exhibits
- 10-K Annual report
- 4.1 Form of Common Stock Certificate
- 21.1 Subsidiaries of the Registrant
- 23.1 Consent of Ernst & Young LLP
- 31.1 Certification of Principal Executive Officer
- 31.2 Certification of Principal Financial Officer
- 32.1 Statement of Principal Executive Officer
- 32.2 Statement of Principal Financial Officer
Related press release
INFIQ similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (Form S-3 No. 333-139641, Form S-8 Nos. 333-138248 and 333-145306) of Infinity Pharmaceuticals, Inc. and in the related Prospectuses of our reports dated March 11, 2008, with respect to the consolidated financial statements of Infinity Pharmaceuticals, Inc., and the effectiveness of internal control over financial reporting of Infinity Pharmaceuticals, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2007.
/s/ Ernst & Young LLP
Boston, Massachusetts
March 11, 2008